Cannabis-Based Drug Sativex Relieves Rheumatoid Arthritis
Friday November 11, 2005
In the first ever controlled trial of a cannabis-based medicine for rheumatoid arthritis, Sativex oromucosal spray (a cannabis-based medicine) produced promising results. Statistically significant improvement was observed in study participants taking the cannabis-based medicine when researchers assessed:
- Pain with movement
- Pain at rest
- Quality of sleep
- Disease activity or progression
Read more about the first study of a cannabis-based medicine to treat rheumatoid arthritis.
Related Resources:
Comments
No comments yet. Leave a Comment